Evidence map›Paper›PMID 39186212›Full record

ArticleJournal of epidemiology and global health2024

Impact of High Covid-19 Vaccination Rate in an Aging Population: Estimating Averted Hospitalizations and Deaths in the Basque Country, Spain Using Counterfactual Modeling.

Carlo Delfin S Estadilla, Javier Mar, Oliver Ibarrondo, Nico Stollenwerk, Maíra Aguiar

Abstract read
In one paragraph

Article in Journal of epidemiology and global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carlo Delfin S EstadillaBCAM-Basque Center for Applied Mathematics, Alameda Mazarredo 14, Bilbao, Basque Country, 48009, Spain.ORCID 0000-0003-3444-0242
Javier MarOsakidetza Basque Health Service, Guipúzcoa, Basque Country, Spain.ORCID 0000-0002-9455-4869
Oliver IbarrondoOsakidetza Basque Health Service, Guipúzcoa, Basque Country, Spain.ORCID 0000-0003-3310-719X
Nico StollenwerkBCAM-Basque Center for Applied Mathematics, Alameda Mazarredo 14, Bilbao, Basque Country, 48009, Spain.ORCID 0000-0001-9315-5586
Maíra AguiarBCAM-Basque Center for Applied Mathematics, Alameda Mazarredo 14, Bilbao, Basque Country, 48009, Spain. maguiar@bcamath.org.ORCID 0000-0001-8354-9944

Funding

Basque Government, Basque Modeling Task Force Project BERC 2022-2025EITB Marathon 2021 call BIO21/COV/001Ministerio de Ciencia e Innovación RYC2021-031380-I
6 · The paper itself

Abstract

COVID-19 vaccines have demonstrated significant efficacy in reducing severe symptoms and fatalities, although their effectiveness in preventing transmission varies depending on the population's age profile and the dominant variant. This study evaluates the impact of the COVID-19 vaccination campaign in the Basque Country region of Spain, which has the fourth highest proportion of elderly individuals worldwide. Using epidemiological data on hospitalizations, ICU admissions, fatalities, and vaccination coverage, we calibrated four versions of an ordinary differential equations model with varying assumptions on the age structure and transmission function. Counterfactual no-vaccine scenarios were simulated by setting the vaccination rate to zero while all other parameters were held constant. The initial vaccination rollout is estimated to have prevented 46,000 to 75,000 hospitalizations, 6,000 to 11,000 ICU admissions, and 15,000 to 24,000 deaths, reducing these outcomes by 73-86%. The most significant impact occurred during the third quarter of 2021, coinciding with the Delta variant's dominance and a vaccination rate exceeding 60%. Sensitivity analysis revealed that vaccination coverage had a more substantial effect on averted outcomes than vaccine efficacy. Overall, the vaccination campaign in the Basque Country significantly reduced severe COVID-19 outcomes, aligning with global estimates and demonstrating robustness across different modeling approaches.

Indexed as

COVID-19COVID-19 VaccinesHospitalizationSARS-CoV-2AdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedSpainVaccinationVaccination CoverageCOVID-19 VaccinesAverted outcomesBasque countryCounterfactual analysisCOVID-19Vaccination impactVaccine

Identifiers

PMID39186212
PMCPMC11442822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.